The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 &lt;sup&gt;68&lt;/sup&gt;Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient management. The gene discussed is FOLH1; the disease is prostate cancer.